Genetic diversity in the quinolone resistance-determining region of gyrA in H. pylori
Abstract
Objective: Levofloxacin (LEV) is the common quinolone antibiotic and a practical option in H. pylori eradication regimens. The LEV resistance can be acquired through variant sequences of a gyrA. This study investigated the correlation between gyrA genetic diversity and LEV resistance in H. pylori. Subject and method: We conducted a cross-sectional study that included 99 H. pylori strains isolated from patients with gastritis, peptic ulcer disease, and gastric cancer at the 108 Military Central Hospital from 2019 to 2022. The minimum inhibitory concentration (MIC) of each strain against levofloxacin was determined using the E-test method. Sanger sequencing was used for variant identification and analysis of gyrA. Mutations were found among both susceptible and non-susceptible strains. Result: Resistance to LEV was observed in 33.3% of the H. pylori isolates, significantly higher in female. Most LEV-resistant strains carry genetic mutations in the quinolone resistance-determining region (QRDR) of gyrA among LEV-resistant strains was remarkably higher than in LEV-sensitive strains. The presence of D91G/Y/N and N87K/I point mutations among non-susceptible was remarkably higher than among susceptible strains. A higher prevalence of mutations outside QRDR (R130K) in resistant strains was also noted. Multiple mutations in the gyrA are only found among resistant strains. All mutant strains exhibited a higher MIC for LEV than wild strains, but statistical significance was only found…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.